Treatment of N-methyl-D-aspartate (NMDA) Enhancers for Schizophrenia

NCT01047592 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

OTHER_GOV

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: sarcosine
DRUG: sarcosine+ BE
DRUG: placebo

Sponsor

Chang-Hua Hospital

Collaborators

[object Object]